The Endometriosis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Endometriosis Market?
The market for endometriosis expanded swiftly in the recent years. From 2024 to 2025, it will increase from $1.4 billion to $1.55 billion, exhibiting a compound annual growth rate (CAGR) of 10.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Endometriosis Industry?
The Endometriosis Global Market is projected to reach a size of $2.21 billion in 2029, with a compound annual growth rate (CAGR) of 9.3%.
Download Your Free Sample of the 2025 Endometriosis Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Endometriosis Market?
The key drivers in the endometriosis market are:
• The prominence of minimally invasive procedures
• Emergence of pharmaceutical innovations
• Advancement in genetic and epigenetic research
• Global expansion of women's healthcare
Global Market Segmentation: Identifying Major Endometriosis Industry Segments
The endometriosis market covered in this report is segmented –
1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types
2) By Treatment Type: Hormonal Therapy, Pain Management
3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs
4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users
Pre-order the 2025 Endometriosis Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Endometriosis Market?
The key trends in the endometriosis market are:
• The market is expected to be influenced by the increase in minimally invasive procedures.
• There is an upsurge in precision medicine and patient-centred care.
• Virtual care and telemedicine are emerging trends shaping the market.
• The trend of fertility preservation is becoming prominent.
Who Are the Top Competitors & Leading Players in the Endometriosis Market?
Major companies in the endometriosis market are:
• Pfizer Inc.
• F. Hoffmann-La Roche AG
• Merck And Co. Inc.
• Abbvie Inc.
• Bayer AG
• Bristol-Myers Squibb Company
• GlaxoSmithKline PLC
• AstraZeneca PLC
• Abbott Laboratories
• Eli Lilly and Company
• Mylan N.V.
• Astellas Pharma Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Limited
• Ipsen Pharma Biotech S.A.S.
• Cadila Pharmaceuticals Ltd.
• Gedeon Richter PLC
• Torrent Pharmaceuticals Ltd.
• Neurocrine Biosciences Inc.
• Ferring Pharmaceuticals
• Prestige Consumer Healthcare Inc.
• Almirall S.A
• Evotec BioSystems GmbH
• Serum Institute of India Pvt. Ltd.
• Kissei Pharmaceutical Co. Ltd.
• Sanofi India Ltd.
• DebioPharm Group
• Repros Therapeutics Inc.
• Meditrina Pharmaceuticals Private Limited
• Zenomed Healthcare Private Limited
Regional Dominance: Which Area Leads the Global Endometriosis Market?
North America was the largest region in the endometriosis market in 2024
